Seamus has managed regulatory submissions for complex products across the world. These have presented him with a range of communication challenges, from language barriers to large variations in regulations, which he has successfully overcome.
After joining Novo Nordisk from university, and despite being the most junior in his team, Peyton was assigned four of the most business-critical projects and delivered on them all.
In response to the lack of awareness of the changes to the In Vitro Diagnostic Regulations (IVDR), Jay Shah and Med-Di-Dia’s Communications Team introduced an effective communication strategy to inform the MedTech industry.
